
é±åéèæ¥èš ç¬¬416å· æ°åã³ãããŠã€ã«ã¹æ²æ» ã®å®çŸæ§ãšã°ãªãŒã³ãŸãŒã³çµæžåãæ°ã³ãçŠã§ã¢ã¡ãªã«ç€ŸäŒã¯çŠè§£ãã€ã€ãããæ ªäŸ¡ã¯å¥œèª¿ãæ¿åºèŠè«ã«ããã¬ã¹ãã©ã³ç޹ä»ã³ãŒããŒã¯äŒæ¢ãæ°ã³ãå¶å§ã®ããã®ãã¯ãæŠè¡ãšãã¯ãæŠè¡ãä»
// é±åéèæ¥èš
// 2020幎4æ21æ¥ ç¬¬416å·
// æ°åã³ãããŠã€ã«ã¹æ²æ»
ã®å®çŸæ§ãšã°ãªãŒã³ãŸãŒã³çµæžå
// æ°ã³ãçŠã§ã¢ã¡ãªã«ç€ŸäŒã¯çŠè§£ãã€ã€ãããæ ªäŸ¡ã¯å¥œèª¿
// æ¿åºèŠè«ã«ããã¬ã¹ãã©ã³ç޹ä»ã³ãŒããŒã¯äŒæ¢
// æ°ã³ãå¶å§ã®ããã®ãã¯ãæŠè¡ãšãã¯ãæŠè¡
// ä»
ãããã«ã¡ã¯ãè€æ²¢æ°åžã§ãã
ãå
é±ããç©æ¥µçã«çµæžã瀟äŒã®æªæ¥äºæ³ãæžãããšã«ããã®ã§ãä»é±ã倧èãªäºæ³ãæžããŸãããä»¥åæžããäžçãã°ãªãŒã³ãŸãŒã³ãšã¬ãããŸãŒã³ã«åããããããããªããšãã話ã®ç¶ãã§ãã
â ä»é±å·ã¯ãã®èŸºã«é¢ä¿ãã話ã§ãã
åæã®æ°è宿ã®ã€ãã³ãã§ã®ææççºããããããŸã§æã蟌ãã§ããŠãæ°åã³ãããŠã€ã«ã¹ãå°ã蟌ããç®åãŸã§æ¥ãŠããéåœã®é²ç«äœå¶ã¯ãããããå°æ¹Ÿã»éåœèŸºãã®é²ç«éšéãäžçæåŒ·ã¯ã©ã¹ã§ããããã https://t.co/9XxIg6Ud2L
â Kazuki Fujisawa (@kazu_fujisawa) April 19, 2020
â
ãããªãã«ãªâŠããšæãããããšãããããçŸå®ã«ãªãå¯èœæ§ãåºãŠããŸããã
ããã§ãããç§ãšãµããŠãã @satobtc ããã1ã¶æã»ã©åã«è°è«ããŠãŸããã
â Kazuki Fujisawa (@kazu_fujisawa) April 19, 2020
ãä»é±ãèªè ããè峿·±ãæçš¿ãããã€ããããŸããèŠã©ããã¯ä»¥äžã®ãšããã§ãã
- ã³ãããåæãããšããŠéœãã£ã¯åŸ©æš©ããŸãã
- åŠ»ã«æ
°è¬æ500äžåãè«æ±ãããŸãããåŒè·å£«ãéã£ãã»ããããã§ãããã
- ã¢ã©ãµãŒããªãã£ãªèé£å¥³åã§ããã³ããã®åœ±é¿ã§ç·æ§ãèªã£ãŠããŸãã
- ãã倧åŠãåºãã®ã«èªå·±åçºã«ããã®ãããå°±è·ããã«å®å®¶ã§åºèŸºããã¬ãŒã§ããã¶ã£ãŠããŸã
- Post COVID-19ã«ãããåãæ¹ãšäœãŸã
- Post COVID-19ã®è²å
ã«ã€ããŠ
-äžå°äŒæ¥æ§åãã«è³éç¹°ãã®ä»äºãããŠããŸããã¿ãªããæ°ã³ãçŠã«å¯Ÿããèªèãçãã§ã
ãããã§ã¯ä»é±ããããããé¡ãããŸãã
ïŒïŒæ°åã³ãããŠã€ã«ã¹æ²æ» ã®å®çŸæ§ãšã°ãªãŒã³ãŸãŒã³çµæžå
ãæ¬æ¥ã®éŠæž¯ã®æ°åã³ãããŠã€ã«ã¹ã®æ°èŠææè æ°ã¯ãŒãã§ããããŸããããŸããŸã§ããããããŸã ãããããšåºãŠããã§ãããããSARSãšåãããã«éŠæž¯ã§ã®æ²æ» ã«çæãããã£ãã®ãããããŸããã
â éŠæž¯ã¯æ¬§ç±³ããã¯ããŠã³ã«äŒŽãåž°åœã©ãã·ã¥ãå°ãã£ãŠãææè æ°ãå€§å¹ å¢å ããŠããã®ã§ãããå šå¡PCRæ€æ»ãšïŒé±ééé¢ã§å ¥åœã®ããŒãã«ãåŒãäžããäžå¯æ¥çš®ã®ããŒãã¯ã©ããå¶æ¥çŠæ¢ã«ããŠããšããšãïŒé±éã¶ãã®æ°èŠææè æ°ïŒã«ãŸã§æ¥ãŸããã
ãŸããããŸããŸã ãããã©éŠæž¯ã¯æ¬æ¥ã®æ°èŠææè æ°ïŒãïŒé±éã¶ããéŠæž¯ãããã¯ããŠã³ããå°ã蟌ãã«åããŠããã°ã£ãŠãã https://t.co/X6U49UFXlV
â Kazuki Fujisawa (@kazu_fujisawa) April 20, 2020
ãä»é±ã¯ïŒæãããã«ç«åŠè ãææçã«è©³ããå»åŠè ãªã©å°éæ§ãé«ã人ãã¡ãšãåã®ãããªæ°ã³ãæŠäºã®ããã³ãã©ã€ã³ã«ç«ã£ãŠããè©è«å®¶ã®éã§éåžžã«ãããã ã£ã話é¡ãåã³è«ããããšæããŸããå°ã蟌ãïŒContainmentïŒãæå¶ïŒå»ç厩å£ããªãããã«ããŒã¯ã«ãããMitigationïŒãããšããè°è«ã§ããããã¯ïŒæã®æåã«æžããã¡ã«ãã¬ã«è§£èª¬ããŸããã®ã§èå³ã®ããæ¹ã¯èªãã§ã¿ããšããã§ãããã
ããã§ã«äœåºŠãæžããŸããããåã¯ïŒæã®æåããæŠæŒ¢ã®ãã¥ãŒã¹ã«æ³šç®ããŠããŸããããªããããããªãã®ã§ãããä»ã®ããšãå¿ããŠããã€ã®éã«ããã®æåæã®é ããæ°åã³ãããŠã€ã«ã¹ã«é¢ãããã¥ãŒã¹ã倢äžã«ãªã£ãŠæ¬¡ããæ¬¡ãžãšãã£ãšèªãã§ããã®ã§ãããããŠãïŒæäžæ¬ã«äºå®ããŠããéŠæž¯ãã£ãºããŒã©ã³ãã®æ
è¡ããéŠæž¯æ¿åºã«ãããã£ãºããŒã©ã³ããçªç¶ééãããŠããŸãããŸã æ¥æ¬äººã®ã»ãšãã©ã«ãšã£ãŠå¯Ÿå²žã®ç«äºã§ããŸã泚ç®ãããŠããªãã£ãããã«åã¯å®éã«æ°åã³ãããŠã€ã«ã¹çŠã«å·»ã蟌ãŸããŠãããŸããã
ãïŒæäžæ¬ã®æç¹ã§ã¯ãåããŸã æ°åã³ãããŠã€ã«ã¹ã¯èŽæ»çããé«ããã®ã®æ¯å¹Žæµè¡ããã€ã³ãã«ãšã³ã¶ãªã©ãšæ¯ã¹ãã°èªåãžã®å¥åº·è¢«å®³ãšããŠã¯å€§ãããã®ã§ã¯ãªãããšããèªèã§ããããããŠãäžåœæ¿åºããããªéœåžå°éãããŠãããã«äžåœå
šåãå€åºå¶éãªã©å³ããããã¯ããŠã³ãã¯ãããŠäœãšãã倧ãããªããšãããŠãããã ããšæã£ãŠããŸãããéŠæž¯ãäžåœæ¬åãšã®åœå¢ãéãããã£ãºããŒã©ã³ããééãããã£ããäœã倧ããã«ãã£ãŠãããã ããšãççŽã«èšã£ãŠãäžåœæ¿åºã¯éå°å¯ŸçãããŠçµæžã§å€§ããªæå€±ãåºãã倱çãããŠãããšæã£ãŠããã®ã§ãããããããã®åŸãããããå匷ããŠãäžåœã®ç ç©¶æ©é¢ãWHOã®è³æãèªã¿ãèªåã§èšç®ãããŠããŠããšã®é倧ãã«æ°ã¥ããããšããã®ã¯ãã§ã«äœåºŠãæžããŸãããã
âæ°åã³ãããŠã€ã«ã¹ïŒCOVID-19ïŒã®æ¬¡ã®ææççºã®å°ã¯æ±äº¬ã«ãªãããã 2020幎2æ15æ¥
http://blog.livedoor.jp/kazu_fujisawa/archives/52168377.html
ãé±åéèæ¥èš ç¬¬407å· æã®ã²ãè¿ããšäžè²«æ§ã«ã€ããŠã2020幎2æ17æ¥
âæ°åã³ãããŠã€ã«ã¹æææ¡å€§ã§æ ªäŸ¡ææ°ã·ã§ãŒãã®"Window of Opportunity"ãïŒ 2020幎2æ24æ¥
http://blog.livedoor.jp/kazu_fujisawa/archives/52168758.html
ãé±åéèæ¥èš ç¬¬413å· å€ãã®èè ãå°éå®¶ãæ°ã³ãçŠãéå°è©äŸ¡ããçç±ãšåäžåœã€ããªãã®ãŒã®äººãã¡ãæ£ããäºæ³ã§ããçç±ã2020幎3æ31æ¥
ãããã§åã¯äžåœæ¿åºã®éœåžå°éãéŠæž¯ãã·ã³ã¬ããŒã«æ¿åºã®é²ç«äœæŠãèŠãŠããŠã©ãã«ãããããªãã£ãããšããããŸãã圌ãããã£ãŠããããšã¯ãå®å
šã«ãŠã€ã«ã¹ã®æ²æ»
ãç®æããŠããŠãåžžèçã«èããŠãããªããšã§ãããããªããããããã«ãªã®ãããšæã£ãŠããã®ã§ããããããçåãæã¡ã€ã€ãïŒæã®æåããããåã¯WHOã®ãã€ãªãŒããªãŒãã£ã³ã°ãæ¯æ¥èŠãŠããŸããããã¹ãŠè±èªã§çæŸéãããŠããŸããã
ãããã§ã¯äºåå±é·ã®ãããã¹åå£«ãæ¬åœã«æ¯æ¥ãæ¯æ¥ãæ°åã³ãããŠã€ã«ã¹ã¯å°ã蟌ãã§ãããããŸååœã察çãè¬ããŠå©ãã°å°ã蟌ãã§ãããæ°åã³ãããŠã€ã«ã¹ã¯å°ã蟌ãå¯èœïŒïŒContainableïŒãªãŠã€ã«ã¹ã ãšç¹°ãè¿ãèšã£ãŠããã®ã§ãããããªãã«ãªïŒã§ãããããªãããšåã¯æã£ãã®ã§ããããããã¹å士ã¯çç©åŠã®åŠäœãæã¡å
¬è¡è¡çã®åéã§PhDãåãããªããšãã£ãŠãWHOã§ãããã«ãªã£ã人ã§ããäžåœã®CDCããéŠæž¯æ¿åºãã·ã³ã¬ããŒã«æ¿åºãåœç¶ã§ãããã«ã§ã¯ãããŸãããããã©ãããããã®åéã®äžççãªãšãã¹ããŒããã¡ãæã£ãŠããŸããããããå Žåã¯ãåœç¶ã§ããèªåã®åžžèãçŽæãçãã¹ãã§ãããããã«ãªã®ã¯ã»ãŒ100ïŒ
åèªèº«ã®ã¯ãã§ãã
ããããã調ã¹ãŠãããšããã®SARSãã¡ãããšäžçã¯å°ã蟌ããŠããããšãç¥ããŸãããSARSã¯æ°åã³ãããŠã€ã«ã¹ãšåæ§ã«ã³ãããŠã€ã«ã¹ã®äžçš®ã§ãããéŠæž¯ãªã©ã²ãšã€ã®ãã³ã·ã§ã³ã§300人以äžã®ææè
ãåºããšãããšãã§ããªãææåã®ãŠã€ã«ã¹ã§ãããããèŽæ»çã¯10ïŒ
è¿ããããŸãããã®æ®ºäººãŠã€ã«ã¹ã¯ææçµè·¯ãäžã€ã²ãšã€å°éã«è¿œè·¡ããŠãææé£éããã¹ãŠæã¡åãããªããšæ°ã¶æã®æéã§éŠæž¯ãªã©SARSã®ææãæ¡å€§ããåœã¯å°ã蟌ãã«æåããã®ã§ããæãã¹ãããšã§ãã
ãã¡ãªã¿ã«ããã®ãšãWHO西倪平æŽäºåå±ã®è²¬ä»»è
ãšããŠãããŸæ¥æ¬ã®ã¯ã©ã¹ã¿å¯Ÿççã§æŽ»èºãããããæŒè°·ä»æ°ãé£é ææ®ã«åœãããŸããã幞éãªããšã«ãããŸæ¥æ¬åœæ¿åºã«å©èšããŠããæ¥æ¬ã®å°éå®¶ã¯ãæŒè°·ææãã¯ããäžæµã°ããã§ãã
âãSARSéå ±ãéŠæž¯ã®SARSãã³ã·ã§ã³é壿æãäžæ°ŽããæµŽå®€ãžã®ãšã¢éæµãäž»å ã 2003幎4æ21æ¥
https://medical.nikkeibp.co.jp/inc/all/hotnews/archives/243013.html
âæ°åã³ãããŠã€ã«ã¹ã«æã
ã¯ã©ã察å³ãã¹ããªã®ã æ±å倧åŠå€§åŠé¢å»åŠç³»ç ç©¶ç§ æŒè°·ä»ææ 2020幎2æ4æ¥
https://www.med.tohoku.ac.jp/feature/pages/topics_214.html